Targeted Treatment for Narcolepsy Type 1
New England Journal of Medicine, Volume 395, Issue 12, Page 1231-1232, September 24, 2026.
We haven't written up this one. NEJM has the full story — the link below goes straight to it.
More in Health & Medicine
Govt Raises Polio Workers Allowance
The Pakistan Polio Eradication Programme has announced a 28 percent increase in the daily allowance of frontline polio workers.
Ukraine seeks pharma tax relief, compensation for destroyed meds – Health Ministry
Ukraine's Ministry of Health is seeking effective mechanisms for compensating for medicines destroyed as a result of attacks by the aggressor and for easing the tax burden on manufacturers and…
After 717 days and nine 'career over' diagnoses, player makes 'surreal' return
Aldershot Town defender Ollie Harfield talks about his return to action after a serious knee injury.
Oveporexton for Narcolepsy Type 1 — Results from Two Phase 3 Trials
New England Journal of Medicine, Volume 395, Issue 12, Page 1166-1179, September 24, 2026.
The Legacy of Orexin (Hypocretin) Research in Narcolepsy and Beyond
New England Journal of Medicine, Volume 395, Issue 12, Page 1237-1240, September 24, 2026.
